+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector Manufacturing"

Vaccines Global Market Opportunities And Strategies To 2031 - Product Thumbnail Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • January 2023
  • 343 Pages
  • Global
From
From
From
From
Viral Vector Manufacturing Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Viral Vector Manufacturing Market - Forecasts from 2020 to 2025

  • Report
  • August 2020
  • 122 Pages
  • Global
From
From
From
From
Loading Indicator

The Viral Vector Manufacturing market is a subset of the genomics industry that focuses on the production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, cystic fibrosis, and hemophilia. The Viral Vector Manufacturing market is highly competitive, with a number of companies offering a range of services. These services include vector design, vector production, and vector characterization. Companies also provide custom services to meet the specific needs of their customers. Some of the major players in the Viral Vector Manufacturing market include Lonza, Thermo Fisher Scientific, Merck KGaA, and Oxford BioMedica. These companies offer a range of services, from vector design to vector production and characterization. Show Less Read more